Drug recall · March 15, 2023
Verapamil Hydrochloride Extended-Release Tablets recall
Why: Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-493-01; NDC Unit Dose: 60687-493-11.
- Lots / codes
Lot 1009065, Exp 12/31/2023
- Quantity
- 422 cartons
- Company
- Amerisource Health Services LLC, Columbus, OH
- Distribution
- Nationwide in the USA
- Initiated
- January 27, 2023 · Voluntary: Firm initiated
- Classified
- March 6, 2023
- Reported
- March 15, 2023
- Ended
- May 12, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Verapamil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.